InvestorsHub Logo
Followers 154
Posts 2652
Boards Moderated 0
Alias Born 01/29/2004

Re: 123tom post# 330953

Friday, 09/24/2021 7:18:04 PM

Friday, September 24, 2021 7:18:04 PM

Post# of 463623
Thanks. Perhaps so.

If you had studied TA chart analysis, trading analysis, and spent 7 years practicing, you would have been ... an AVXL Monster.

Thanks.

But, I haven’t spent much time at all studying or learning technical analysis. Way back in the 1980s, I watched Louis Rukeyser’s Wall Street Week on public TV. It was my introduction to stock investing; very thorough and important.

But in each Friday evening show, he’d show not only the week’s stock market moves, but he’d also have a segment on what TA, technical analysis, was showing and predicting.

For me, that part of the show was very much like my reading your posts here. Lots of numbers and charts, all showing or revealing important trends and directions.

But, just as I’m not sufficiently knowledgeable about what you post, I was even less clear about Rukeyser’s TA guests. Interesting to watch; but not information I could (or would) act on. Couldn’t confidently understand or apply it.

Conversely, here, the same may well be with my postings on the biomolecular details of the Anavex molecules, acting in neurons. To comprehend much of that, it helps to have taken (and passed) some undergraduate (or advanced placement) cellular biology courses. Most readers, here, have not. Understood. No offense taken when my Anavex science postings are dismissed.

But everything will become clearly seen and understood, when the three on-going blarcamesine clinical trials end, and their very positive results are announced. Then, comprehension of either TA or cellular biology will not be needed. The whole world be begin to understand how Anavex will change medical practice in the rest of the century.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News